Page last updated: 2024-12-10
4,7-diphenylphenanthroline sulfonate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4,7-diphenylphenanthroline sulfonate: color reagent for serum iron [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3036973 |
SCHEMBL ID | 2392734 |
MeSH ID | M0043638 |
Synonyms (6)
Synonym |
---|
4,7-diphenylphenanthroline sulfonate |
4,7-diphenyl-1,10-phenanthroline-2-sulfonic acid |
einecs 255-084-3 |
4,7-diphenyl-1,10-phenanthrolinesulphonic acid |
SCHEMBL2392734 |
DTXSID90961212 |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"The bioavailability of iron from foods is ultimately determined by interactions between iron and other components in the digestive milieu." | ( In vitro studies of iron bioavailability. Probing the concentration and oxidation-reduction of pinto bean iron with ferrous chromogens. Bates, GW; Chidambaram, MV; Reddy, MB; Thompson, JL, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.05) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |